Recent studies have shown that the treatment of nonmetastatic K-1735 murine melanoma cells with cytokines induces the production of nitric oxide (NO) and hence cell death. The purpose of this study was to determine the mechanism of this cytokine-induced NOmediated apoptosis. Incubation of nonmetastatic K-1735 cells with interleukin-1 alpha (IL-1a) and interferongamma (IFN-g) induced high NO production, Bcl-2 downregulation, and apoptotic cell death. In contrast, incubation of metastatic K-1735 cells with IL-1a and IFN-g did not induce signi®cant production of NO, downregulation of Bcl-2, or cell death. The exposure to exogenous NO derived from the NO donors, sodium nitroprusside (SNP), or GEA5024 produced a dosedependent apoptotic cell death in both the metastatic and nonmetastatic K-1735 cells, which was associated with downregulation of Bcl-2 at the mRNA level and, to a lesser extent, at the protein level. Nonmetastatic and metastatic K-1735 cells transfected with the Bcl-2 gene were more resistant to apoptosis mediated by both endogenous and exogenous NO. Subsequent to intravenous injection, the tumor cells transfected with the Bcl-2 gene had an increased survival rate in the lungs of nude mice and produced a higher number of experimental lung metastases. These data suggest that NO-induced apoptosis in K-1735 melanoma cells is associated with downregulation of Bcl-2.
Introduction
To produce metastasis, tumor cells must complete a series of linked and highly selective steps that favor the survival of subpopulations of metastatic cells preexisting in the heterogeneous primary tumor (Fidler, 1990 (Fidler, , 1995 Radinsky, 1991) . During hematogenous metastasis, tumor cells are subjected to extreme selection pressures that lead to the death of the majority of tumor cells that enter the circulation (Fidler, 1970; Weiss, 1986; Glaves, 1986) . For example, early studies on the organ distribution and fate of B16 melanoma cells labeled with 125 I-5-iodo-2'-deoxyuridine ([ 125 I]IdUrd) showed that less than 0.1% of circulating tumor cells can survive to proliferate into metastases (Fidler, 1970) . Similarly, nonmetastatic cells of murine K-1735 melanoma undergo a more rapid destruction in the circulation than metastatic cells .
Aspects of tumor cells, such as deformibility (Sato and Suzuki, 1976) , aggregation (Nicolson, 1986) , and cell surface adhesion molecules (Hofmann et al., 1991; Frixen et al., 1991) , and those of the host, such as blood turbulence (Sato and Suzuki, 1976; Weiss and Dimitrov, 1986) , platelets (Sugimoto et al., 1987; Tsuruo et al., 1986) , T-cells (Wiltrout et al., 1979) , natural killer cells (Hanna and Fidler, 1980; Herberman, 1989) , and macrophages (Fidler, 1985; Whitworth et al., 1990) , all contribute to the destruction or survival of blood-borne tumor emboli. Moreover, the passage of tumor cells through capillaries leads to cell lysis by sheer force of movement (Sato and Suzuki, 1976; Weiss and Dimitrov, 1986) and by nitric oxide (NO) produced by cytokine-activated endothelial cells (Li et al., 1991a, b; Geng et al., 1996) .
Most normal cells depend on speci®c factors in the organ environment to maintain their viability and function (Williams et al., 1990; Neiman et al., 1991; Ra et al., 1993; Cyster et al., 1994; Boudreau et al., 1995) . This dependence may be what prevents normal cells from uncontrolled growth and from migration to inappropriate sites. Metastatic cells, on the other hand, can circumvent this homeostatic mechanism and therefore survive at site(s) dierent from the tissue from which they arose (Fidler, 1990 (Fidler, , 1995 Thompson, 1995) . Indeed, the outcome of metastasis depends upon multiple interactions between tumor cells and the host environment (Fidler, 1995) . Recent studies have shown that exposure to various pro-in¯ammatory cytokines can induce the expression of the inducible nitric oxide synthase (iNOS) gene and production of high levels of endogenous NO in nonmetastatic K-1735 murine melanoma cells but not in metastatic K-1735 melanoma cells, demonstrating an inverse correlation between iNOS expression and metastatic potential (Dong et al., 1994) . NO is a major cytotoxic molecule produced by macrophages in defense against various pathogens (Nathan, 1992) . The induction of iNOS and production of endogenous NO in the tumorigenic cells may represent another important part of the host defense mechanism against cancer.
Recent data have led to the conclusion that a family of genes homologous to human Bcl-2 and ced-9 in C. elegans plays a central role in the regulation of apoptosis. In particular, the overexpression of Bcl-2 has been shown to increase the resistance of cells to apoptosis induced by a variety of stimuli, which includes oxidative stress (Hockenbery et al., 1993; Kane et al., 1993; Fang et al., 1995) . Whether downregulation of Bcl-2 is involved in NO-mediated apoptosis remains unclear. This report demonstrates that apoptosis induced by endogenous and exogenous NO is indeed associated with the downregulation of Bcl-2.
Results

Endogenous NO-mediated apoptotic cell death in melanoma cells
In the ®rst set of experiments, we determined the production of NO and apoptotic cell death in nonmetastatic C10, C19, and C23 cells and in metastatic C4 and X21 cells. As shown in Figure 1 , treatment of cells with both interferon-gamma (IFN-g) and interleukin-1 alpha (IL-1a) induced a high level of NO ( Figure 1a ) and extensive cell death (Figure 1b) in the nonmetastatic C10, C19, and C23 melanoma cells. The same treatment did not induce signi®cant levels of NO or cell death in the metastatic C4 and X21 cells. The addition of NMA, a speci®c iNOS inhibitor, totally inhibited NO production and cell death. These results lead us to conclude that the induction of endogenous NO leads to death of tumor cells via induction of apoptosis.
To con®rm that NO-mediated cell death occurred by apoptosis, metastatic X21 and nonmetastatic C19 cells were treated with IFN-g and IL-1a for 48 h, and DNA fragmentation was analysed by agarose gel electrophoresis. The cytokines clearly induced typical oligonucleosomal DNA fragmentation in the nonmetastatic C19 cells, but not in the metastatic X21 cells ( Figure  2a1 and 2a2), in direct correlation with cell death (Figure 1b ). Both DNA fragmentation and cell death were inhibited by the addition of NMA (Figure 2a1 and 2a2). The fragmented DNA in apoptotic C19 cells was further visualized in situ by the TUNEL technique. The percentage of apoptotic cells observed under inverted microscopy was consistent with the percentage of TUNEL-positive cells (Figure 2b2 ), which was inhibited by the addition of NMA (Figure 2b3 ).
Inverse correlation between iNOS and Bcl-2
We next investigated the relationship between NO production and Bcl-2 gene expression. K-1735 cells were incubated in either medium alone or in medium containing IFN-g and IL-1a. The level of iNOS, Bcl-2, p53, and GAPDH transcripts was measured by Northern blot analyses. Enhanced NO production was associated with iNOS mRNA expression in the cytokine-treated nonmetastatic cells, whereas no iNOS induction was observed in the metastatic cells ( Figure   Figure 1 Dierential induction of NO and apoptosis in metastatic vs nonmetastatic cells. Nonmetastatic C10, C19, and C23 cells and metastatic C4 and X21 cells were incubated in medium alone or medium containing 100 U/ml IFN-g plus 10 ng/ ml IL-1a for 48 h. NO production (a) was determined by measuring nitrite accumulation in the culture supernatant, and the percentage of apoptotic cells (b) were determined under Contrast Optics on a Nikon inverted microscope (*P50.001) 3) and nonmetastatic C19 (lanes 4 to 6) cells were incubated in medium alone (lanes 1 and 4) or in medium containing 100 U/ml IFN-g plus 10 ng/ml IL-1a (lanes 2, 3, 5 and 6) in the presence (lanes 3 and 6) or absence (lanes 1, 2, 4 and 5) of NMA for 48 h. The small DNA fragment was isolated and separated on a 1.5% agarose gel. (a2) Nonmetastatic C19 cells were incubated in medium alone or medium containing 100 U/ml IFN-g plus 10 ng/ ml IL-1a in the presence or absence of NMA for indicated times. The small DNA fragment was isolated and separated on a 1.5% agarose gel. Note that the cytokine combination induced typical apoptotic DNA fragmentation in nonmetastatic cells, which was inhibited by the iNOS inhibitor NMA. (b) Nonmetastatic C19 cells were incubated in medium (b1), medium containing 100 U/ml IFN-g plus 10 ng/ml IL-1a (b2), or medium containing 100 U/ml IFN-g plus 10 ng/ml IL-1a and 2 mM NMA (b3) for 48 h. Apoptotic nuclei (indicated by arrows) were visualized by TUNEL 3a1 and 3a2). The treatment of C10, C19, and C23 cells with IFN-g and IL-1a signi®cantly decreased the level of Bcl-2 mRNA transcripts. The increase in p53 mRNA transcripts was not signi®cant (Figure 3a1 ). IFN-g and IL-1a did not produce signi®cant changes in Bcl-2 gene expression in the metastatic C4 and X21 cells (Figure 3a2 ). The cytokine-induced changes in the Bcl-2 or p53 gene expression were time-dependent ( Figure 3b1 ) and were reversed by the addition of NMA (Figure 3b2 ), suggesting that endogenously produced NO modulated the expression of these genes.
Exogenous NO-mediated modulation of Bcl-2 expression
Cytokines trigger complex signal transduction pathways in cells and any or all of the components of these pathways could be involved in the alterations in Bcl-2 and p53 observed in our study. Therefore, to further study the relationship between NO production and Bcl-2 expression, we analysed the eects of the NO donor GEA5024, which spontaneously releases NO into the culture medium, on apoptosis and Bcl-2 expression. Preliminary studies demonstrated that GEA5024 induced dose-and time-dependent apoptosis in both nonmetastatic and metastatic cells. Transient treatment of cells with GEA5024 (560 min) did not result in apoptosis. For gene expression studies, we used concentrations of GEA5024 that produced less than 20% cytotoxicity. As shown in Figure 4a1 and 4a2, incubation with GEA5024 for 24 h induced a dosedependent decrease in Bcl-2 expression in both metastatic X21 ( Collectively, these data demonstrate that both metastatic and nonmetastatic cells are sensitive to exogenous NO-mediated apoptosis, which is associated with modulation of Bcl-2 expression. Moreover, there data suggest that differential modulation of Bcl-2 by the cytokines. IFN-g and IL-1a results from the dierential iNOS expression and NO production.
Increased resistance to NO-mediated apoptosis by transfection with Bcl-2 gene
To provide direct evidence that Bcl-2 plays a role in tumor cell survival and metastasis, we transfected both nonmetastatic C19 and metastatic X21 cells with the human Bcl-2 gene expression vector. The control cells were transfected with a vector carrying the neomycinresistant gene. To avoid clonal variation, more than 10 hBcl-2-positive clones (expressing human Bcl-2 protein) were pooled and used in the experiments. To investigate whether the inhibition of cytokine-induced NO-dependent apoptosis in Bcl-2-transfected cells was due to the suppression of iNOS expression, we treated both Bcl-2-transfected (C19.hBcl-2) cells and control vector-transfected (C19.Neo) cells with cytokines as above. Both exogenous hBcl-2 and iNOS proteins were determined by Western blot analyses. The overexpression of hBcl-2 did not aect iNOS expression ( Figure  6a ). The resistance to endogenous NO-mediated apoptosis was investigated only in C19 cells because X21 cells do not express iNOS. The C19 cells were incubated for 48 h with IFN-g and IL-1a, as stated in Figure 1 . Transfection with hBcl-2 totally inhibited the were incubated in medium alone or in medium containing 100 units/ml IFN-g plus 10 ng/ml IL-1a for 24 h. mRNA was isolated for Northern blot analysis of iNOS, Bcl-2, p53, and GAPDH transcripts. (b) Nonmetastatic C19 (b1) cells were incubated in MEM or MEM containing 100 units/ml IFN-g plus 10 ng/ml IL1a for 0 to 24 h. Nonmetastatic C19 (b2) cells were incubated in MEM or MEM containing 100 units/ml IFN-g plus 10 ng/ml IL1a in the presence or absence of 3 mM NMA for 24 h. mRNA was isolated for Northern blot analyses of iNOS, Bcl-2, p53 and GAPDH transcripts. The ratios between the speci®c mRNA and GAPDH are shown in italics cytokine-induced NO-mediated apoptosis in the C19 cells (Figure 6b ). The parental tumor cells or tumor cells transfected with either hBcl-2 or control vector were then incubated in medium alone or medium containing GEA5024 for 24 h to determine the sensitivity to exogenous NO-mediated apoptosis. The apoptosis percentage of both C19 and X21 cells was determined were also incubated in MEM or MEM containing 40 mM GEA5024 for 6 to 24 h. Cytosolic protein was isolated for Western blot analysis of Bcl-2 and p53. b-actin was also probed to monitor equal protein loading. In parallel experiments, the C19 cells were treated with either GEA5024 (b) or SNP (e), and percentage of apoptotic cells was determined under contrast optics on a Nikon inverted microscope. The ratios between the speci®c protein and b-actin are shown in italics. *P50.001 (Student's t test) as compared to untreated control cells under an inverted microscope with phase-contrast optics. Both C19 and X21 cells overexpressing hBcl-2 protein were more resistant to GEA5024-mediated apoptosis (Figure 6c ). The dierence in apoptosis between hBcl-2-transfected cells and control cells was statistically signi®cant (P50.001) as determined by the two-tailed Student's t test.
In vivo survival and metastatic potential of control and Bcl-2 transfected cells
In the ®nal set of experiments, we injected control and Bcl-2-transfected tumor cells into groups of nude mice (n=5). The percentage of cells surviving in the lungs was determined 48 h after the i.v. injection. As shown in Figure 6d , no discernible dierences in survival of cells were found between parental tumor cells and cells transfected with a control vector. In contrast, hBcl-2-transfected tumor cells had a signi®cant increase (P50.001) in survival in the lungs. In a parallel experiment, groups of nude mice (n=5) were injected i.v. with the tumor cell lines. The incidence and number of experimental lung metastases were determined 35 days later. The transfection of highly metastatic cells (C4 and X21) with the hBcl-2 gene always produced an increased number of experimental lung metastases, whereas nonmetastatic cells transfected with hBcl-2 showed an increased survival in the lung that was not immediately followed by an increase in metastatic potential. Thus, transfection of C19 and C10 cells with the hBcl-2 gene increased the production of metastasis but similar transfection of C23 did not.
Discussion
Our present results demonstrate that cytokines can induce apoptotic cell death in nonmetastatic K-1735 cells. Because the nonmetastatic cells expressed relatively higher levels of Bcl-2, we investigated whether the upregulation of iNOS and the subsequent generation of NO could directly aect Bcl-2 expression and/or function. Stimulation of endogenous NO production with cytokines resulted in a marked decrease of Bcl-2 expression and in a modest upregulation of p53 gene expression in nonmetastatic K-1735 cells but not in metastatic K-1735 cells. However, the introduction of exogenous NO (using NO donors) resulted in a marked decrease of Bcl-2 mRNA and protein and in a modest upregulation of p53 gene expression in both nonmetastatic and metastatic K-1735 cells. Tumor cells transfected with the hBcl-2 gene under control of the long-terminal repeat promoter became more resistant to both endogenous and exogenous NO-mediated apoptosis and had an increased survival in the circulation and lung capillary bed of nude mice. These results indicate that the modulation of iNOS expression and NO production are associated with downregulation of Bcl-2 and apoptosis of K-1735 melanoma cells. NO is a free radical generated from the oxidation of the terminal quinidine nitrogens of L-arginine (Nathan, 1992) . The reaction is catalyzed by the enzyme nitric oxide synthase (NOS). The inducible NOS (iNOS or NOS2) is found in many cell types, especially in activated macrophages and endothelial cells (Hibbs et al., 1987; Li et al., 1991a,b; Nathan, 1992) . Several steps of metastasis can be in¯uenced by NO. NO regulates vasodilatation (Palmer et al., 1988; Ignarro et al., 1990) and inhibits platelet aggregation (Radomski et al., 1990a,b) , which leads to a decrease in the arrest of tumor cell emboli in capillary beds and, hence, to a decrease in metastasis (Fidler, 1970 (Fidler, , 1990 Sugimoto et al., 1987; Tsuruo et al., 1986) . NO derived from capillary endothelium may also kill tumor cells (Li et al., 1991a,b; Geng et al., 1996) . Recent studies using iNOS gene transfection have shown that the transfection of metastatic murine melanoma cells (that do not produce NO) with the full-length iNOS gene leads to production of NO and suppression of the metastatic potential. The same cells transfected with a truncated iNOS gene did not produce NO and retained their metastatic potential (Xie et al., 1995b (Xie et al., , 1997 , suggesting that high levels of NO cause self-destruction of tumor cells. Transfection with Bcl-2 leads to increased resistance to NO-mediated apoptosis, better survival in the capillary bed of the lung, and enhanced metastatic potential. Taken together, these observations suggest that Bcl-2 can protect circulating tumor cells from NOmediated apoptosis and thus play an important role in tumor growth and metastasis. Conversely, transient and low levels of NO might bene®t tumor growth by increasing blood supply. For example, a human colon cancer clone transfected with the murine iNOS gene produced low levels of NO. Although the transfected cells grew more slowly in culture, they produced faster growing s.c. tumors in nude mice (Jenkins et al., 1995) .
Cytokines or endotoxins can induce iNOS expression in many murine and human cells. The subsequent production of NO can induce an array of eects ranging from protection from cell death to induction of cell death (Xie et al., 1993 (Xie et al., , 1995a (Xie et al., , 1996a . One of the major factors involved in determining cellular response to NO is the NO output, which can vary among dierent cells and among inducers of iNOS activities (Xie et al., 1996a) . For example, IL-1b induces apoptotic cell death in pancreatic b cells by low level of NO production (Kaneto et al., 1995) . In contrast, a low level of NO can protect ovarian follicles from hormone-induced apoptosis (Chun et al., 1995) . A high level of endogenous or exogenous NO has been shown to promote apoptotic and necrotic cell death, whereas trace levels of NO can do the reverse (Martin-Sanz et al., 1996a) . The variable responses could also be due to dierences in the cellular anti-oxidant machinery (Xie et al., 1996a) . For example, upregulation of specialized resistance genes such as MnSOD, G6PDH and GST, may counteract the destruction by high output of NO (Bergelson et al., 1994; Corrazilia et al., 1993; LewisMolock et al., 1994) . De®ciencies in the antioxidant machinery may render cells vulnerable to low physiological levels of NO, or deregulated high NO output can overwhelm the normal antioxidant machinery and lead to cellular damage (Schmidt and Walter, 1994; Xie et al., 1996a) . Parallel generation of other reactive oxygen intermediates can amplify the eects of a nontoxic level of NO, leading to cell destruction under certain circumstances (Beckman et al., 1994; Schmidt and Walter, 1994) . Speci®cally, the reaction of NO with superoxide is known to generate peroxynitrite, which produces extensive protein tyrosine nitrisation and thus can be more cytotoxic than either NO or superoxide (Beckman et al., 1994) .
The biochemical and molecular mechanisms underlying apoptosis are under active investigation. Recent work suggests that Bcl-2 and p53 are involved in the apoptosis of at least certain cell types. For example, the accumulation of the tumor suppressor p53 has been shown to precede apoptotic cell death of some (Brune et al., 1995) , but not all (Elmore et al., 1996) cells. Cellular p53 levels varied with the level of NO. NO induced a dose-dependent accumulation of p53, but high concentrations of NO eliminated accumulation of p53. A possible explanation is that low NO may produce accumulation of p53 by DNA damage (Wink et al., 1991) , whereas high NO might shut down overall biosynthesis (Lepoivre et al., 1990) . Apoptosis however can occur under both circumstances.
Recent ®ndings have shown that NO-mediated apoptosis is inhibited by Bcl-2 (Xie et al., 1996b) , which is consistent with reports showing that Bcl-2 plays an important role in regulating cellular redox status and cellular response to oxidative stress. In particular, Bcl-2 has been shown to delay apoptosis in lymphoid cells exposed to exogenous hydrogen peroxide and to prevent lipid peroxidation in cells treated with a variety of other stimuli (Hockenbery, 1992 , Hockenbery et al., 1993 . Moreover, Bcl-2 can interfere with reactive oxygen species-mediated cell death in neurons, the eects of which are linked to upregulation of endogenously reduced glutathione levels (Kane et al., 1993) . In this study, the metastatic K-1735 cells were more sensitive to exogenous NOmediated apoptosis as compared to nonmetastatic counterparts. This is consistent with our recent data showing that sensitivity of tumor cells to NO is inversely correlated with Bcl-2 expression (Xie et al., 1996b) .
The association of NO with Bcl-2 expression is unclear. In EBV-transformed B lymphocytes and Burkitt's lymphoma cell lines, endogenous and exogenous (donor molecules) NO inhibits apoptosis (Mannick et al., 1994) through a mechanism involving sustained levels of Bcl-2 (Genaro et al., 1995) . In murine melanoma cells, the high level of NO is associated with a decrease in Bcl-2 expression and an increase of apoptosis. This apparent discrepancy may be due to the use of murine versus human cells. The Bcl-2 homologue, Bcl-X L , has been shown to modify the response of cells to endogenously produced oxidants (Fang et al., 1995) . Whether other members of the Bcl-2 family like Bcl-X L also play a role in NOmediated apoptosis is currently under investigation.
In summary, we have demonstrated that endogenous and exogenous NO can modulate the apoptosis suppressor Bcl-2. Overexpression of the Bcl-2 gene through transfection of hBcl-2 increased the resistance of tumor cells to both endogenous and exogenous NOmediated apoptosis. The identi®cation of NO as a potential negative regulator for oncogenes such as Bcl-2 may lead to therapy for metastasis.
Materials and methods
Reagents
Eagle's minimal essential medium (MEM), Hanks' balanced salt solution (HBSS), and fetal bovine serum (FBS) were purchased from M.A. Bioproducts. [Methyl- 3 H] thymidine ([ 3 H]TdR, speci®c activity, 20 Ci/mmol) and 125 I-5-iodo-2'-deoxyuridine ([ 125 I]IdUrd, speci®c activity, 2000 Ci/mmol) was purchased from ICN Biomedicals, Inc. N G -methyl-L-arginine (NMA), sodium nitroprusside (SNP) and GEA5024 were purchased from Alexis Biochemicals, and murine IFN-g and IL-1a were purchased from Genzyme. All reagents used in tissue culture were free of endotoxin as determined by the Limulus amebocyte lysate assay (sensitivity limit, 0.125 ng/ml) purchased from Associates of Cape Cod.
Cell lines and culture
The original K-1735 melanoma induced in a C3H/HeN mouse by exposure to u.v. light followed by painting with croton oil was a gift to Dr Margaret L Kripke, The University of Texas M.D. Anderson Cancer Center, Houston, TX (Kripke, 1979) . The parental tumor was cloned in vitro by a double-dilution method (Fidler and Talmadge, 1986) . Of the large number of clones thus isolated, clones 10, 19 and 23 (designated C10, C19 and C23) were classi®ed as nonmetastatic or low metastatic . Clone 4 (C4) is highly metastatic and produces melanotic tumor foci in the lungs of syngeneic mice. Clones M2 and X21 were derived from dierent solitary, spontaneous lung metastases produced by the K-1735 parental line growing s.c. Both were shown to be clonal in origin (Talmadge et al., 1982; Fidler and Talmadge, 1986) and highly metastatic in syngeneic mice (Fidler and Talmadge, 1986) . All K-1735 lines were at passages 6 to 10 from the original cloning procedure or isolation from metastases. Both metastatic and nonmetastatic clones express wild-type p53 (Xie et al., unpublished data) . The cultures were maintained for no longer than 3 weeks after recovery from frozen stocks. All cell lines were maintained in tissue culture in MEM supplemented with 10% FBS, sodium pyruvate, nonessential amino acids, Lglutamine, and twofold vitamin solution. Cell cultures were maintained on plastic and incubated in 5% CO 2 ± 95% air at 378C. The cultures were free of mycoplasma and the following murine viruses: retrovirus type 3, pneumonia virus, K virus, Theiler's encephalitis virus, Sendai virus, minute virus, mouse adenovirus, mouse hepatitis virus, lymphocytic choriomeningitus virus, ectromelia virus, and lactate dehydrogenase virus (assayed by M.A. Bioproducts).
NO production
Endogenous NO production was determined by measuring nitrite accumulation in culture supernatants as described by Ding et al. (1988) . Brie¯y, 50 ml samples were harvested from conditioned medium and allowed to react with an equal volume of Griess reagent (1% sulfanilamide-0.1% naphthylethylene diamine dihydrochloride-2.5% H 3 PO 4 ) at room temperature for 10 min. The absorbance at 540 nm was monitored with a microplate reader. Nitrite concentration was determined by using sodium nitrite as a standard.
Fate of intravenously injected cells and production of experimental lung metastases
Tumor cells were incubated for 24 h in medium containing 0.3 mCi/ml [ 125 I]IdUrd. The cultures were washed several times with warm HBSS and then treated for 2 min with 0.25% trypsin-0.02% EDTA. The¯asks were tapped to dislodge the cells, and the cells were suspended in Ca 2+ -and Mg 2+ -free HBSS at a ®nal concentration of 10 5 cells per 0.2 ml, the inoculum volume per mouse. Labeled cells were injected i.v. into unanesthetized mice, and groups of ®ve mice were killed at intervals thereafter. Lung, liver, kidneys and spleen of each mouse were collected and placed in test tubes containing 70% ethanol. The ethanol was replaced daily for 3 days to remove all soluble 125 I released from dead cells (Fidler, 1970) . The radioactivity in all of the organ samples was determined using a gamma counter (Gamma-Trac model 1185: TM Analytic). Triplicate input tubes (containing 0.2 ml of inoculum) were retained, and the radioactivity was counted at the same time as the sample organs. The mean counts in organs from each group of ®ve animals per time point were expressed as the percentage of input counts. Measurements were corrected for radioactivity decay in input cells (Fidler, 1970) .
To produce experimental lung metastasis, 1610 5 viable tumor cells were injected into the lateral tail vein of unanesthetized nude mice. The mice were killed 5 weeks later, and the lungs were removed, rinsed in water, and ®xed in Bouin's solution to dierentiate the neoplastic lesions from the organ parenchyma. The lung nodules were counted with the aid of a dissecting microscope.
Analysis of gene expression
The Bcl-2 mRNA was determined by Northern blot analysis using Bcl-2 cDNA probe (a generous gift from Dr Timothy J McDonnell, M.D. Anderson Cancer Center, Houston, TX). Bcl-2 protein expression was determined by Western blot analysis using hamster antimouse Bcl-2 (Pharmigen) according to published procedure Xie et al., 1996b) . p53 mRNA was analysed by using probe of exon 5, which was generated by PCR. The p53 protein was detected using polyclonal anti-mouse p53 (Oncogene Science). The equal loading was monitored by hybridizing the same membrane ®lter with cDNA probe for GAPDH in Northern blots and b-actin in Western blots. The expression level of both mRNA and protein was quanti®ed by densitometry of autoradiograms using the ImageQuant software sample measurement calculated from the ratios of the average areas between the speci®c mRNA transcripts and GAPDH mRNA transcripts (Northern blots) or between the speci®c protein and bactin protein (Western blot) in the linear range of the ®lm.
Apoptosis and DNA laddering assay
The percentage of apoptotic cells was determined morphologically according to a published procedure with the aid of contrast optics on a Nikon inverted microscope (Lin and Chou, 1992) . Apoptosis was also analysed by agarose gel electrophoresis of internucleosomal DNA fragments according to reported methods (Xie et al., 1992) with the following modi®cations. Brie¯y, 5610 6 tumor cells were seeded in triplicate into 100 mm tissue culture dishes, incubated 4 to 6 h at 378C, and then washed and refed with medium alone or medium containing NO donors for the indicated time. The cells were then collected by a cell scraper and centrifuged at 2000 g for 10 min. The cell pellets were suspended in lysis buer consisting of 8 mM EDTA, 20 mM Tris, pH 8.0 and 0.2% (v/v) Triton X-100. After 20 min at room temperature, the lysates were centrifuged at 13 000 g for 5 min. The low molecular weight DNA in the postnuclear supernatant was treated with proteinase K and precipitated with ethanol at 7708C overnight after extraction with phenol and chloroform. The DNA was then pelleted and dissolved in TE buer and treated with RNase I. Equivalent amounts of materials from 3610 6 cells were loaded and electrophoresed on a 1.5% agarose gel. The gel was stained with 1 mg/ml ethidium bromide and photographed with Polaroid type 55 ®lm using a u.v. transilluminator and an MP-3 Polaroid camera setup.
In situ visualization of apoptotic cells by terminal deoxynucleotidy transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) Tumor cells were cultured on chamber slides and treated with cytokines. Forty-eight hours later, cells were ®xed with 4% paraformaldehyde for 20 min at room temperature. The cells were then treated with 20 mg/ml proteinase K for 15 min at room temperature and rinsed in water. The endogenous peroxidase was inactivated by incubation of cells with 2% H 2 O 2 in methanol for 5 min. After being rinsed in water and TdT buer (30 mM Trizma Base, pH 7.2, 140 mM sodium cacodylate, 1 mM cobalt chloride), the cells were incubated in TdT (1:400) plus dUTP-biotin (1:100 dilution in TdT buer) for 45 to 60 min at 378C.
After being rinsed in TB buer (300 mM sodium chloride, 30 mM sodium citrate), the cells were incubated for 15 min at room temperature in TB buer to terminate the reaction. The cells were rinsed with water and then covered with a 2% aqueous solution of bovine serum albumin (BSA) for 10 min at room temperature before being incubated with Strepavidin-conjugated alkaline phosphatase (Dako) diluted 1:10 ± 1:20 in water for 30 min at 378C. Finally, the cells were washed, stained with 3-amino,9-ethylcarbazole for about 30 min at 378C, counterstained with aqueous hematoxylin and photographed (Radinsky et al., 1994; Huang et al., 1996) .
Bcl-2 gene and transfection
For stable transfection, monolayer cultures (30% conuence) of C19 and X21 cells were transfected with pZipBcl-2 plasmid with a full-length human Bcl-2 (hBcl-2) gene under the control of constitutive long terminal retreat promoter or pZip-Neo plasmid without the hBcl-2 insert (generous gifts of Dr John C Reed, La Jolla Cancer Institute, La Jolla, CA) as control using the stable mammalian transfection kit from Stratagene. The individual G418-resistant (500 to 800 mg/ml, GIBCO-BRL) colonies were isolated and established as individual cell lines and maintained in medium containing G418. The hBcl-2 expression was screened by Western blot analysis using rabbit anti-human Bcl-2 monoclonal anti-human Bcl-2 (Dako) according to a published procedure (Xie et al., 1996b) . To avoid clonal variation, at least 10 positive clones were pooled for further experiments.
Statistical analyses
The signi®cance of the in vitro data was analysed by the Student's t test (two-tailed), and the in vivo data were analysed by the Mann-Whitney U test.
